Published: November 24, 2010
Medical Breakthrough Safe Visible Light Sterilization for MRSA
By John McCormick
While it has long been known that ultra violet (UV) radiation can kill many kinds of bacteria, UV light intensive enough to do much good in hospital settings is damaging to human eyes.
Recent studies have shown that high intensity narrow spectrum (HINS) visible wavelength light, not UV, centered on the 405 nm wavelength is both effective in killing MRSA and a range of other bacteria in patient rooms, it is also safe for human exposure without special protection.
The HINS LED lighting tested is effective in greatly reducing the possibility of infection from various gram positive and gram negative bacteria as well as some fungi.
Adding other LEDs producing different visual light wavelengths can make this into a standard lighting system for hospital rooms.
See the following article for a list of the bacteria and fungi shown susceptible to HINS UV light.
Clinical trials were conducted at the Glasgow (Scotland) Royal Infirmary.
John McCormick is a reporter, /science/medical columnist and finance and social commentator, with 17,000+ bylined stories. Contact John through NewsBlaze.
If you leave a comment and it does not display within 10 seconds, please refresh the page
Pharmacyclics, Inc. today announced that The New England Journal of Medicine published results of a Phase 2 study evaluating the investigational oral Bruton's tyrosine kinase inhibitor ibrutinib in patients with relapsed/refractory mantle cell ...
Pfizer, GSK, and Siemens Form R&D Consortium With A*STAR's Institute of Chemical & Engineering Sciences
Surgeons from Children's Hospital LA recently returned from a medical mission in Amman, Jordan. They treated 44 Jordanian children in need of specialized plastic surgery.
Johnson City Med. Center is the first hospital in Tenn. to implement the Xenex system, which has been credited for helping other hospitals in the U.S. decrease their MRSA and C.diff infection rates.
Baylor and Scott & White sign definitive agreement; announce structure of new organization, headquarters, key leadership and board structure; expect to close by end of year, pending customary reviews.
Transaction Transforms Wright Medical into High Growth Extremities and Biologics Pure Play and Expands Growth Opportunities for OrthoRecon Business Purchase Price of $290 Million Cash Wright to Host Conference Call Thursday, June 20, 2013, at 8:00 ...